View Press Releases
-
Prodigious Reimbursements on Advanced Detectors Creating Conducive Environment for a-Si X-ray Flat Panel Detectors Market, finds Fact.MR
DUBLIN, IRELAND - Dec 9, 2019 - High productivity ensured by digital a-Si x-ray flat panel detectors over analogue ones is encouraging medical professionals to switch to these novel devices
Dec 9, 2019
-
Iceni Diagnostics researcher sheds light on glycogen with fluorescent probe
NORWICH, UNITED KINGDOM - Dec 9, 2019 - Glucose provides the energy for life and is stored as glycogen in the liver and muscles. Gaia Fancellu, of Iceni Diagnostics, is using fluorescent probe technology to better understand the structure and metabolism of glycogen – the bodys sugar storage material
Dec 9, 2019
-
Scilligence and Certara Partner to Improve Client’s Data Analysis and Visualization
CAMBRIDGE, MA, UNITED STATES - Dec 5, 2019 - Scilligence, an innovation leader of unified informatics platform for biologics and small molecules drug R&D, has partnered with Certara to enable advanced data analysis and visualization capabilities
Dec 5, 2019
-
CluePoints’ Risk-Based Quality Management Software Wins Best Technological Development in Clinical Trials at SCRIP Awards 2019
KING OF PRUSSIA, PA - Dec 5, 2019 - CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, today announced that it has been awarded best technological development in clinical trials in the 2019 Scrip Awards
Dec 5, 2019
-
VeraSci's Innovation Lab Launches Wearable Technology Validation Study
DURHAM, NC, UNITED STATES - Dec 4, 2019 - VeraSci's Innovation Lab led by Dr. Alexandra Atkins has begun evaluating the ease of use, sensitivity, and reliability of two industry-grade wearable devices for the real-time capture of gait and actigraphy measuresx
Dec 4, 2019
-
FDA Awards DNAnexus with Five-Year, $20 Million Contract to Power precisionFDA Collaborative Omics Environment in the Cloud
MOUNTAIN VIEW, CA, UNITED STATES - Dec 3, 2019 - DNAnexus, Inc., the leader in Enterprise Omics Technology, today announced that the U
Dec 3, 2019
-
Absolute Antibody Partners with the Recombinant Antibody Network to Facilitate Access to Engineered Recombinant Antibodies
REDCAR, UNITED KINGDOM - Dec 3, 2019 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with the Recombinant Antibody Network (RAN), a consortium of three expert centers at the University of Chicago, University of Toronto, and UC San Francisco (UCSF) with a common goal to generate recombinant antibodies at a proteome-wide scale
Dec 3, 2019
-
Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration to accelerate neuroscience-focused research
CAMBRIDGE AND LONDON, UNITED KINGDOM - Dec 3, 2019 - Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and LifeArc, a leading UK independent medical research charity, today announced an extension of their neuroscience-focused ion channel drug discovery collaboration, following the success of the initial twelve-month agreement
Dec 3, 2019
-
Hypha Discovery announces “One-Stop Metabolite Shop” solution to support pharmaceutical and agrochemical R&D
SLOUGH, UK - Dec 3, 2019 - Hypha Discovery Limited, a leading specialist CRO, has launched its One-Stop Metabolite Shop to provide a complete solution for provision of small molecule drug metabolites to pharmaceutical and agrochemical companies worldwide
Dec 3, 2019
-
TrialScope Launches Clinical Trials Website for EMD Serono
JERSEY CITY, NJ, UNITED STATES - Dec 2, 2019 - TrialScope, the global leader in clinical trial transparency and disclosure compliance solutions, has worked with EMD Serono, the North American branch of the healthcare business of Merck KGaA, Darmstadt, Germany, to launch a new website, https://clinicaltrials
Dec 2, 2019
-
One Nucleus announces finalists of the BioNewsRound Award
LONDON, UK - Nov 28, 2019 - One Nucleus reveals the finalists of its annual BioNewsRound Award, recognising life science companies that have announced exciting developments for patients and the sector
Nov 28, 2019
-
Creative Peptides Provides Photo Cross Linkers for Custom Labeling in Peptide Modification
NY, NY, UNITED STATES - Nov 28, 2019 - The global leading peptide supplier Creative Peptides announces to release a product line of photo cross linkers for researchers who are engaged with custom labeling, peptide bioconjugation as well as peptide modification
Nov 27, 2019
-
Enzymes for Cancer Treatment Manufactured by Creative Enzymes Have Set New Pace for Medical Science
NEW YORK, NY - Nov 28, 2019 - Creative Enzymes, a cutting-edge enzyme product and service provider based in NY, USA, has recently published enzymes for cancer treatment to help scientists in the area of medicine
Nov 27, 2019
-
BOC Sciences Rearranges Chemical Analysis and Purification Service for Drug Discovery Projects
SHIRLEY, NY, NY, UNITED STATES - Nov 28, 2019 - In response to the ever-increasing demand in new drug discovery and development, medicinal chemistry has progressed at a fast pace during the last ten years
Nov 27, 2019
-
Signant Health Joins the Association of Clinical Research Organizations (ACRO) to Add a Technology Perspective to Industry Conversations
PHILADELPHIA, PA - Nov 27, 2019 - Signant Health announced today that it has joined the non-profit Association of Clinical Research Organizations (ACRO)
Nov 27, 2019
-
Prokarium announces MHRA acceptance to run Phase I trial of lead vaccine against enteric fever
LONDON, UK - Nov 26, 2019 - Prokarium, a private biotechnology company developing vaccines against infectious diseases and immunotherapy for solid tumors, has received Clinical Trial Authorization (CTA) acceptance from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to run a first-in-human Phase I trial with Entervax, a bivalent vaccine against enteric fever
Nov 25, 2019
-
SAKOR Technologies Announces Dynamometer Line for Testing Electric Motor Efficiency to Meet International Environmental Standards
OWOSSO, MI, UNITED STATES - Nov 25, 2019 - For Immediate ReleaseContact: Judi Handel McNeil, Gray & Rice 617-367-0100 ext
Nov 25, 2019
-
Debiopharm Implements Dotmatics to Improve Data-Driven Decision-Making
BISHOP'S STORTFORD, UNITED KINGDOM - Nov 25, 2019 - Debiopharm International SA, the drug development company focused on oncology and infectious diseases, has implemented tools from Dotmatics, a leading provider of scientific informatics solutions and services, to re-engineer its data management processes to support its continuous growth
Nov 25, 2019
-
Potential findings on whole genome sequencing for cancer treatment was made
SHIRLEY, NY, UNITED STATES - Nov 25, 2019 - In recent years, individualized treatments will benefit more cancer patients as the time and cost of whole genome sequencing decreases
Nov 24, 2019
-
Spring Bank Announces Dosing of Patients in Phase 1 Clinical Trial of IV-Administered STING Agonist, SB 11285
HOPKINTON, MA, UNITED STATES - Nov 20, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced that it has initiated dosing patients in a Phase 1 trial of SB 11285, the companys intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist
Nov 21, 2019